Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1151-1160 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|July 6, 2016
In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidateLiuxi Chen, Lan Wang, Henry Shion, et al.
Mabs|February 19, 2016
An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugatesYi Li, Christine Gu, Jason Gruenhagen, et al.
Mabs|February 25, 2016
Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USAMatthias Pauthner, Jenny Yeung, Chris Ullman, et al.
Mabs|February 25, 2016
The application of mathematical modelling to the design of bispecific monoclonal antibodiesTamara J van Steeg, Kirsten Riber Bergmann, Nazzareno Dimasi, et al.
Mabs|March 11, 2016
Humanized mouse G6 anti-idiotypic monoclonal antibody has therapeutic potential against IGHV1-69 germline gene-based B-CLLDe-Kuan Chang, Vinodh B Kurella, Subhabrata Biswas, et al.
Mabs|March 11, 2016
Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidityAndrew D Tustian, Christine Endicott, Benjamin Adams, et al.
Mabs|December 18, 2014
Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014James W Larrick, Paul W H I Parren, James S Huston, et al.
Mabs|December 18, 2014
Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancerSaskia Meyer, Jeanette H W Leusen, Peter Boross
Mabs|December 18, 2014
Physicochemical characterization of RemsimaSoon Kwan Jung, Kyoung Hoon Lee, Jae Won Jeon, et al.
Mabs|December 18, 2014
Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programsAlex Colbert, Amber Umble-Romero, Samantha Prokop, et al.
Pageof 178

Showing results (1151-1160 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|July 6, 2016
In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidateLiuxi Chen, Lan Wang, Henry Shion, et al.
Mabs|February 19, 2016
An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugatesYi Li, Christine Gu, Jason Gruenhagen, et al.
Mabs|February 25, 2016
Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USAMatthias Pauthner, Jenny Yeung, Chris Ullman, et al.
Mabs|February 25, 2016
The application of mathematical modelling to the design of bispecific monoclonal antibodiesTamara J van Steeg, Kirsten Riber Bergmann, Nazzareno Dimasi, et al.
Mabs|March 11, 2016
Humanized mouse G6 anti-idiotypic monoclonal antibody has therapeutic potential against IGHV1-69 germline gene-based B-CLLDe-Kuan Chang, Vinodh B Kurella, Subhabrata Biswas, et al.
Mabs|March 11, 2016
Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidityAndrew D Tustian, Christine Endicott, Benjamin Adams, et al.
Mabs|December 18, 2014
Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014James W Larrick, Paul W H I Parren, James S Huston, et al.
Mabs|December 18, 2014
Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancerSaskia Meyer, Jeanette H W Leusen, Peter Boross
Mabs|December 18, 2014
Physicochemical characterization of RemsimaSoon Kwan Jung, Kyoung Hoon Lee, Jae Won Jeon, et al.
Mabs|December 18, 2014
Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programsAlex Colbert, Amber Umble-Romero, Samantha Prokop, et al.
Pageof 178